HNF, Rarebase Project Working to Find New Therapies for CMT

HNF, Rarebase Project Working to Find New Therapies for CMT

309023

HNF, Rarebase Project Working to Find New Therapies for CMT

The Hereditary Neuropathy Foundation, known as HNF, is joining forces with Rarebase, a biotech company, on a project that aims to identify potential treatments for multiple different types of Charcot-Marie-Tooth disease (CMT). It is the first research initiative to tackle multiple types of CMT in one project, according to the HNF, a U.S.-based nonprofit. “We’re thrilled to be collaborating with the HNF to help find treatments for patients with CMT,” Onno Faber, co-founder and CEO…

You must be logged in to read/download the full post.